Glaxosmithkline | DŁUG



Debt Zmiana Data
AbbVie USD 69.89B 2.74B 2025-03
Amgen USD 57.38B 2.72B 2025-03
AstraZeneca USD 32.84B 1.19B 2025-06
Aurora Cannabis CAD 100.98M 11K 2024-12
Bausch Health Companies USD 21.51B 106M 2025-03
Bristol-Myers Squibb USD 50.93B 1.22B 2025-06
Canopy Growth CAD 489.67M 123.85M 2024-12
Corcept Therapeutics USD 0 0 2025-03
Drreddys Laboratories INR 51.08B 2.55B 2024-12
Eli Lilly USD 38.52B 4.87B 2025-03
GlaxoSmithKline GBP 17.35B 1.08B 2025-06
Glaxosmithkline GBP 16.99B 927M 2024-12
J&J USD 52.25B 15.62B 2025-03
Merck USD 34.84B 2.27B 2025-03
Novartis USD 31.27B 12M 2025-03
Pacira USD 583.38M 1.94M 2025-03
Perrigo USD 3.63B 9.4M 2025-03
Pfizer USD 62.11B 2.24B 2025-03
Prestige Brands USD 1.02B 18.52M 2025-03
Roche Holding CHF 34.44B 5.23B 2024-06
Sanofi 21.05B 3.14B 2025-03
Supernus Pharmaceuticals USD 0 0 2024-12
Takeda JPY 4.51T 9.32B 2025-06
Teva Pharmaceutical Industries USD 16.65B 1.43B 2025-03
Zoetis USD 6.58B 7M 2025-03


Glaxosmithkline DŁUG - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.